Market Access and Reimbursement: The Increasing Role of Real-World Evidence.

@article{Pietri2014MarketAA,
  title={Market Access and Reimbursement: The Increasing Role of Real-World Evidence.},
  author={Guilhem Pietri and P Masoura},
  journal={Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
  year={2014},
  volume={17 7},
  pages={A450-1}
}
Randomized controlled trials (RCTs) have historically been considered the primary source of evidence to support decision-making in market access and reimbursement. However, thanks to significant progress in capturing data through computerized systems and making these data available, real-world evidence (RWE) has been increasingly considered by manufacturers… CONTINUE READING